HIGHFDA DEVICE

Vascutek Gelsoft Plus and Gelweave Vascular Prostheses Recalled for Shelf-Life Label Error (37,430,

Vascutek recalled 37,430 Gelsoft Plus and Gelweave vascular prostheses distributed nationwide in the United States after discovering the devices were labeled with an extra month of shelf life. The expiry date was calculated from packaging rather than gel impregnation. Healthcare providers and patients should stop using the devices immediately and follow recall instructions.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
December 18, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
December 18, 2025
Hazard Level
HIGH
Brand
Vascutek
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Vascutek
Product type
Gelatin-sealed vascular prostheses
Model numbers
635024PE, 635024PE-B, 631514PE, 631514PE-B, 631222PE, 631222PE-B, 633008PE, 633008PE-B +47 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    December 18, 2025

  2. Reported by FDA DEVICE

    March 11, 2026

  3. RecallRadar source check

    March 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Gelatin sealed woven polyester prostheses devices, designed for vascular repair, were incorrectly labeled with an additional month of shelf life. Device expiry should have been calculated from gel impregnation (date of manufacture) but it was incorrectly calculated from device packaging.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Vascutek, Ltd. or your healthcare provider for instructions. Notification method: Letter

About This Product

Gelsoft Plus and Gelweave vascular prostheses are implanted during vascular repair surgeries to replace or bypass diseased arteries.

Why This Is Dangerous

The expiry date was miscalculated because labeling relied on packaging rather than the gel impregnation manufacturing date. This could lead to use of expired devices or confusion about shelf life.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Hospitals must audit inventory and notify patients. Replacements or refunds may cause procedural delays. No injuries have been reported yet.

Practical Guidance

How to identify if yours is affected

  1. Identify Gelsoft Plus and Gelweave vascular prostheses in use at hospitals or clinics.
  2. Check device REF numbers listed in the recall notice.
  3. Verify expiry date against the gel impregnation manufacture date, not packaging date.
  4. Audit inventory to isolate affected devices.

Where to find product info

Expiry and manufacturing data are on device packaging and labeling; recall letters provide specifics.

What timeline to expect

Refund or replacement processing typically 4-8 weeks after notification.

If the manufacturer is unresponsive

  • Escalate to hospital compliance or procurement personnel.
  • Document all correspondence with the manufacturer.
  • File a formal complaint with FDA recall authorities if needed.

How to prevent similar issues

  • Verify expiry dates during procurement
  • Keep recall contact information for suppliers
  • Inspect packaging to ensure expiry reflects gel impregnation date

Documentation advice

Retain recall letter, packaging photos, model numbers, receipts, and all correspondence.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Gelsoft Plus devices with REF numbers including 635024PE, 631514PE, 631222PE, 633008PE, 633010PE, 633007PE, 636010PE, 632522PE, 633012PE, 635018PE, 631516PE, 636016PE, 631220PE, 631608PE, 631206PE, 631407P50E, 631508PE among others. Gelweave devices include REF numbers such as 736038E, 736036E, 736034E, 736032E, 736030E, 736028E, 736026E, 736024E, 736022E, 736020E, 736018E, 736016E, 736014E, 736012E, 736010E, 736008E, 736006E, and related variants. Total quantity recalled: 37,430. Distribution: United States nationwide.

Key Facts

  • Distribution: US nationwide
  • Gelsoft Plus REFs include multiple models
  • Gelweave REFs include multiple models
  • Expiry mislabeling calculated from packaging, not manufacture

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
635024PE
635024PE-B
631514PE
631514PE-B
631222PE
+50 more
Affected States
ALL
Report Date
March 11, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

LACTATED RINGERS
Presence of
Read more